Cahaba Wealth Management Inc. Reduces Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Cahaba Wealth Management Inc. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,660 shares of the company’s stock after selling 308 shares during the period. Cahaba Wealth Management Inc.’s holdings in HCA Healthcare were worth $1,894,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Bangor Savings Bank grew its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the second quarter valued at $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at about $28,000. GPS Wealth Strategies Group LLC increased its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. purchased a new position in HCA Healthcare in the 2nd quarter valued at $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 2.2 %

Shares of HCA stock traded up $9.06 on Friday, reaching $415.54. 1,093,996 shares of the stock were exchanged, compared to its average volume of 1,139,995. The stock has a market cap of $108.84 billion, a P/E ratio of 20.72, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a 50 day moving average of $392.18 and a two-hundred day moving average of $350.18. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company posted $4.29 earnings per share. On average, research analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,202 shares of company stock valued at $6,407,273. Corporate insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Oppenheimer upped their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. KeyCorp assumed coverage on shares of HCA Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $475.00 price target on the stock. Barclays upped their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Finally, Royal Bank of Canada lifted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $365.65.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.